As of 2025-07-06, the EV/EBITDA ratio of Pharming Group NV (PHARM.AS) is 31.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PHARM.AS's latest enterprise value is 666.91 mil EUR. PHARM.AS's TTM EBITDA according to its financial statements is 21.18 mil EUR. Dividing these 2 quantities gives us the above PHARM.AS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 12.1x | 10.4x |
| Forward P/E multiples | 12.0x - 16.0x | 13.8x |
| Fair Price | 0.18 - 0.41 | 0.29 |
| Upside | -79.4% - -54.1% | -67.6% |
| Date | EV/EBITDA |
| 2025-07-04 | 31.49 |
| 2025-07-03 | 31.43 |
| 2025-07-02 | 31.55 |
| 2025-07-01 | 31.23 |
| 2025-06-30 | 32.04 |
| 2025-06-27 | 32.70 |
| 2025-06-26 | 32.90 |
| 2025-06-25 | 32.78 |
| 2025-06-24 | 32.79 |
| 2025-06-23 | 31.75 |
| 2025-06-20 | 32.05 |
| 2025-06-19 | 31.96 |
| 2025-06-18 | 32.90 |
| 2025-06-17 | 33.71 |
| 2025-06-16 | 34.32 |
| 2025-06-13 | 33.85 |
| 2025-06-12 | 35.39 |
| 2025-06-11 | 35.36 |
| 2025-06-10 | 36.13 |
| 2025-06-09 | 36.00 |
| 2025-06-06 | 36.29 |
| 2025-06-05 | 35.27 |
| 2025-06-04 | 37.45 |
| 2025-06-03 | 36.16 |
| 2025-06-02 | 35.49 |
| 2025-05-30 | 34.38 |
| 2025-05-29 | 33.47 |
| 2025-05-28 | 32.50 |
| 2025-05-27 | 33.56 |
| 2025-05-26 | 32.73 |
| 2025-05-23 | 32.61 |
| 2025-05-22 | 32.90 |
| 2025-05-21 | 33.23 |
| 2025-05-20 | 31.81 |
| 2025-05-19 | 30.74 |
| 2025-05-16 | 30.24 |
| 2025-05-15 | 29.48 |
| 2025-05-14 | 29.53 |
| 2025-05-13 | 30.78 |
| 2025-05-12 | 30.82 |
| 2025-05-09 | 31.76 |
| 2025-05-08 | 31.38 |
| 2025-05-07 | 27.30 |
| 2025-05-06 | 27.81 |
| 2025-05-05 | 28.20 |
| 2025-05-02 | 28.37 |
| 2025-04-30 | 27.72 |
| 2025-04-29 | 27.56 |
| 2025-04-28 | 26.98 |
| 2025-04-25 | 26.72 |